Quality in pharmaceutical primary packaging involves more than dimensions and appearance; it also concerns contamination, mix-ups, changes, and production conditions. An acceptable inspection report may not be enough to explain how an entire batch was controlled. ISO 15378 planning can connect packaging use and pharmaceutical customer quality agreements back to evidence for materials, processes, and release.
Who may need this and when
Organizations that design, manufacture, or supply primary packaging for medicinal products can assess applicability based on product-contact use and their actual responsibilities. Review the system when taking a new pharmaceutical order, adding a material or process, receiving an audit request, or changing outsourcing arrangements.
Common business challenges
The same packaging serves different customers with inconsistent cleaning, change-notification, and retention requirements; site teams inspect dimensions but do not address contamination or mix-up risks; or batch data is split among production, quality, and subcontractors, making release completeness difficult to confirm.
Approach and applicable requirements
The ISO catalogue lists ISO 15378:2017 and Amendment 1:2024 as specific quality-management requirements for primary packaging materials for medicinal products, incorporating good manufacturing practice and referencing ISO 9001:2015. Do not change the edition referenced by this standard merely because a general quality standard has been updated; do not describe all outer packaging as primary packaging.
Possible scope includes quality responsibilities and documents; personnel hygiene and environment; materials and suppliers; outsourcing and change control; batch production and inspection; product preservation and release; and applicable validation of equipment, processes, cleaning, or computerized systems. Connect deviations, complaints, and recall information to causes and improvement, and include follow-up in training and internal review.
Support and work stages
Define packaging and customer conditions
Organize contact use, material, process, site, and quality agreements into applicable requirements and a gap list.
Review contamination and mix-up risks through the process
Review personnel and material flows, cleaning, line clearance, and identification to confirm that procedures reflect site conditions. Outputs may include an operational gap list and control-owner register.
Sample a batch for traceability and validation
Trace a batch from materials to delivery, and organize existing validation evidence and technical items still needed. Do not treat complete forms as a substitute for judging effectiveness.
Bring deviations and complaints back into management
Review a real event, including response, cause, actions, and effectiveness, then identify topics for internal audit and management review follow-up.
Information to prepare
Prepare packaging specifications and intended use, customer quality agreements, process and site layouts, material sources and batch records, cleaning and environmental records, validation evidence, and deviation, complaint, and recall procedures. Preserve the applicable scope of each customer’s requirements.
Assessing schedule and fees
Effort depends on material and process types, differences between customers, number of sites, and quality of existing evidence. Test-method development, technical validation, engineering improvements, and third-party certification should be scoped separately, with customer acceptance conditions confirmed.
Frequently asked questions
Does this apply to all pharmaceutical packaging?
First confirm that the item is primary packaging for a medicinal product and clarify the organization’s role. The packaging name alone is not enough.
If we already have ISO 9001, what differences remain?
Review requirements specific to primary packaging and GMP, such as hygiene, contamination prevention, batch control, and applicable validation.
Is an acceptable appearance and dimension check enough for release?
Release should follow applicable specifications and quality requirements and confirm that required process and inspection evidence is available.
Can one customer quality agreement be used for everyone?
A common management method can be used, but each customer’s notification, inspection, and change conditions must remain identifiable.
Can existing validation reports be reused?
Confirm that the product, process, and conditions remain applicable, and have competent personnel assess the impact of changes.
Does system planning mean the pharmaceutical customer will accept the packaging?
Customer acceptance, regulatory requirements, and third-party certification each have their own basis and should be confirmed separately.
Related services and enquiries
See ISO 9001 for common quality processes. When discussing primary-packaging needs with Captain International, provide an overview of the material, intended use, and the customer’s main requirements.